Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Shukra Pharmaceuticals Limited is engaged in the field of Pharmaceuticals. They started their operations with a fully integrated plant in Rakanpor in Kalol, Gandhinagar - Gujarat. Even since its incorporation, the company has grown to immense heights in terms of operations and has expanded largely. Today, they have an internationally accredited Laboratory in Ahmedabad for creating each product on the highest quality standards.
Shukra Pharmaceuticals undertake operations including-
The team of research analysts, medical officers, and technical experts of Shukra Pharmaceuticals ensure quality in each product and follow stringent regulations to deliver the same.
| Issue Open | February 15, 2023 - February 28, 2023 |
| Security Name | Shukra Pharmaceuticals Limited |
| Issue Size (Shares) | 9,394,050 |
| Issue Size (Amount) | ₹18.79 Crores |
| Issue Price | ₹20 per share |
| Face Value | ₹10 per share |
| Listing At | BSE |
| Terms of Payment | Rs. 5 per Rights Equity Share to be paid on Application and balance to be paid in three calls as determined. |
| Entitlement | 6 Equity Shares for every 1 Fully Paid Equity Share held |
| Record Date | February 2, 2023 |
| Credit of Rights Entitlements | February 13, 2023 |
| Bid/Offer Opens On | February 15, 2023 |
| Renunciation of Rights Entitlements | February 23, 2023 |
| Bid/Offer Closes On | February 28, 2023 |
| Deemed Date of Allotment | March 8, 2023 |
| Credit Date | March 14, 2023 |
| Listing Date | March 15, 2023 |
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth |
|---|---|---|---|---|
| 31-Mar-21 | 35.61 | 11.55 | 0.19 | 15.60 |
| 31-Mar-22 | 35.11 | 20.57 | 0.75 | 16.35 |
| Amount in ₹ Crore | ||||
The Company proposes to utilize the Net Proceeds to:
3 3.3 Rating:  Vote Here ... |
Shukra Pharmaceuticals Limited
Veer House, 3rd Floor, Judges Bungalow Road,
Opp. WIAA Motor Training School,
Bodakdev, Ahmedabad- 380054
Phone: +91 79 48901030
Email: info@shukrapharmaceuticals.com
Website: http://www.shukrapharmaceuticals.com/#
Purva Sharegistry India Pvt Ltd
Phone: +91-022-23018261/ 23016761
Email: support@purvashare.com
Website: https://www.purvashare.com/investor-service/ipo-query
The Shukra Pharmaceuticals Rights Issue 2023 opens on February 15, 2023, and closes on February 28, 2023.
Shukra Pharmaceuticals Rights Issue 2023 Schedule
| Last Date for credit of Rights Entitlements | February 13, 2023 |
| Last Date for renunciation of Rights Entitlements | February 23, 2023 |
| Issue Opening Date | February 15, 2023 |
| Issue Closing Date | February 28, 2023 |
| Date of Allotment (on or about) | March 8, 2023 |
| Date of Credit (on or about) | March 14, 2023 |
| Date of Listing (on or about) | March 15, 2023 |
Shukra Pharmaceuticals Rights Issue 2023 price is set at ₹20 per share per equity share.
The eligible shareholders are being offered 6 Equity Shares for every 1 Fully Paid Equity Share held (February 2, 2023).
The record date for the Shukra Pharmaceuticals Rights Issue 2023 is February 2, 2023.
The issue size of Shukra Pharmaceuticals Rights Issue 2023 is of 9,394,050 equity shares at ₹20 per share aggregating upto ₹18.79 Crores.
The Letter of Offer for Shukra Pharmaceuticals Rights Issue 2023 can be download here.
You can apply for Shukra Pharmaceuticals Rights Issue 2023 in two ways:
Steps to apply for Shukra Pharmaceuticals Rights Issue 2023 using Net Banking (ASBA)
Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.
Steps to apply for Shukra Pharmaceuticals Rights Issue 2023 using Registrar's website (R-WAP)
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
